2024: $973.3 million
2025: $978.7 million (0.55% YoY)
2026: $983.6 million (0.50% YoY)
2027: $988.1 million (0.46% YoY)
2028: $992.3 million (0.42% YoY)
CAGR (2024-2028): 0.48%
Future trends to watch for include the impact of emerging healthcare policies in Türkiye, technological advancements in treatment methods, and the prevalence of obstructive airway diseases. There is potential for increased R&D investment by pharmaceutical companies, which may influence future sales dynamically.
